CD163 and its role in inflammation

Folia Histochemica et Cytobiologica

Volumn 49, Issue 3, 2011, Pages 365-374

  Kowal, Krzysztof ^a   Silver, Richard ^b   Sławińska, Emila ^a   Bielecki, Marek ^a   Chyczewski, Lech ^a   Kowal Bielecka, Otylia ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CD163; Inflammation

Indexed keywords

CD163 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ANTIGEN BINDING; BINDING AFFINITY; BINDING SITE; CD163 GENE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXON; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY DISEASE; MACROPHAGE; MONOCYTE; NONHUMAN; PROMOTER REGION; REVIEW; UPREGULATION;

EID: 84856780598     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0052     Document Type: Review

References (68)

1. Auffrey C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Ann Rev Immunol. 2009;27:669-692.
2. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327:656-661.
3. Yona S, Yung S. Monocytes: subsets, origin, fate and function. Current Opin Hematol. 2010:17:53-59.
4. van Gorp H, Delputte PL, Nauwynck HJ. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell directed therapy. Mol Immunol. 2010; epub.
5. Sarrias MR, Gronlund J, Padilla O, Madsen J, Holmskov U, Lozano F. The scavenger receptor cysteines-rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol. 2004;24:1-37.
6. Fabriek BO, Polfliet MM, Vioet RP et al. The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood. 2007;109:5223-5229.
7. Ritter M, Buechler C, Langmann T, Schmitz G. Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Comm. 1999; 260:466-474.
8. Law SKA, Micklem KJ, Shaw JM et al. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol. 1993;23:2320-2325.
9. Ritter M, Buechler C, Langmann T, Orso E, Klucken J, Schmitz G. The scavenger receptor CD163: regulation, promoter structure and genomic organization. Pathobiology. 1999;67:257-261.
10. Schaer DJ, Boretti FS, Hongegger A et al. Molecular cloning and characterization of the mouse CD163 homologue, a highly glucocorticoid-inducible member of the scavenger receptor cysteines-rich family. Immunogenetics. 2001;53:170-177.
11. Schaer DJ, Schoeden G, Schaffner A. Assignment of the CD163 antigen (Cd163) to mouse chromosome 6 band F2 by radiation hybrid mapping. Cytogenet Genome Res. 2002; 98:231.
12. Radzun HJ, Kriepe H, Bodewadt S, Hansmann ML, Barth J, Parwaresch MR. Ki-M8 monoclonal antibody reactive with and intracytoplasmic antigen of monocyte/macrophage lineage. Blood. 1987;69:1320-1327.
13. Moller HJ, Peterslund NA, Graversen JH, Moestrup SK. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood. 2002;99:378-380.
14. Backe E, Schwarting R, Gerdes J, Ernst M, Stein H. Ber-Mac3: a new monoclonal antibody that defines human monocyte/ macrophage differentiation antigen. J Clin Pathol. 1991;44:936-945.
15. Hogger P, Dreier J, Droste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteines-rich family (CD163). J Immunol. 1998;161:1883-1890.
16. Sulahian TH, Hogger P, Wahner AE et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine. 2000;12:1312-1321.
17. Moniuszko M, Kowal K, Rusak M, Pietruczuk M, Dabrowska M, Bodzenta-Lukaszyk A. Monocyte CD163 and CD36 expression in human whole blood and isolated mononuclear cell samples: influence of different anticoagulants. Clin Vaccin Immunol. 2006;13:704-707.
18. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti- -inflammatory stimuli. J Leukoc Biol. 2000;67:97-103.
19. +, peripheral blood monocytes in severe asthmatic patients. Clin Immunol. 2009;130:338-346.
20. Van den Heuvel MM, Tensen CP, van As JH et al. Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol. 1999;66: 858-866.
21. Topoll HH, Zwadlo G, Lange DE, Sorg C. Phenotypic dynamics of macrophage subpopulations during experimental gingivitis. J Peridont Res. 1989;24:106-112.
22. Zwadlo G, Voegeli R, Schultze, Osthoff K, Sorg C. A mAb to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol. 1987;55:295-304.
23. Schaer DJ, Boretti FS, Schoedon G, Schaffner A. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol. 2002;119:239-243.
24. Varga G, Ehrchen J, Tsianakas A et al. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leukoc Biol. 2008;84:644-650.
25. Williams L, Jarai G, Smith A, Finan P. IL-10 expressing profiling in human monocytes. J Lekoc Biol. 2002;72:800-809.
26. Hogger P, Erpenstein U, Rohdewald P, Sorg C. Biochemical characterization of a glucocorticoid-induced membrane protein (RM3/1) in human monocytes and its application as a model system for ranking glucocorticoid potency. Pharm Res. 1998;15:296-302.
27. + regulatory T cell induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA. 2007;104:19446-19451.
28. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J Leukoc Biol. 2007;81:663-671.
29. Hintz KA, Rassias AJ, Wardwell K et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol. 2002;72:711-717.
30. Gleissner CA, Shaked I, Erbel C, Bockler D, Katus HA, Ley K. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ Res. 2010;106:203-211.
31. Pioli PA, Goonan KE, Wardwell K, Guyre PM. TGF-b regulation of human macrophage scavenger receptor CD163 is Smad3-dependent. J Leukoc Biol. 2004;76:500-508.
32. Etzerodt A, Maniecki MB, Moller K, Moller HJ, Moestrup SK. Tumor necrosis factor alpha - converting enzyme (TACE/ /ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol. 2010; epub.
33. Timmermann M, Hogger P. Oxidative stress and 8-iso-prostaglandin F2a induce ectodomain shedding of CD163 and release of tumor necrosis factor-a from human monocytes. Free Radic Biol Med. 2005;39:98-107.
34. Bosco MC, Puppo M, Santangelo C et al. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol. 2006;177:1941-1955.
35. Sulahian TH, Pioli PA, Wardwell K, Guyre PM. Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163. J Lekoc Biol. 2004;76: 271-277.
36. Matushita N, Kashiwagi M, Wait R et al. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Exp Immunol. 2002;130:156-161.
37. Kowal K, Moller HJ, DuBuske LM, Moestrup SK, Bodzenta- -Łukaszyk A. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergen-induced bronchoconstriction. Clin Exp Allergy. 2006;36:1584-1591.
38. Fabriek BO, Moller HJ, Vloet RP et al. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmunol. 2007;187:179-186.
39. Daly DA, Walsh C, Feighery C, O'Shea U, Jackson J, Whelan A. Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease. Aliment Pharmacol Ther. 2006;24:553-559.
40. Moller HJ, Moestrup SK, Weiss N et al. Macrophage serum markers in pneumococcal bacteriemia: prediction of survival by soluble CD163. Crit Care Med. 2006;34:2561-2566.
41. Knudsen TB, Larsen K, Kristiansen TB et al. Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: comparison with CRP and procalcitonin. Scand J Infect Dis. 2007; 39:542-253.
42. Knudsen TB, Gustafson P, Kronborg G et al. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin Microbiol Infect. 2005;11:730-735.
43. Aristoteli LP, Moller HJ, Bailey B, Moestrup SK, Kritharides L. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis. 2006;184:342-347.
44. Moller HJ, de Fost M, Aerts H, Hollak C, Moestrup SK. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur J Haematol. 2004;72:135.
45. + macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondyloarthropathy synovitis. Arthritis Rheum. 2004;50:1611-1623.
46. Zwadlo-Klarwasser G, Bent S, Haubeck HD, Sorg C, Schmutzler W. Glucocorticoid-induced appearance of the macrophage subtype RM3/1 in peripheral blood of man. Int Arch Allergy Appl Immunol. 1990;91:175-180.
47. Yaeger MP, Pioli PA, Wardwell K et al. In vivo exposure to high or low cortisol has biphasic effects on inflammatory response pathways of human monocytes. Anasth Analg. 2008;107:1726.
48. van den Heuvel MM, Tensen CP, van As JH et al. Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol. 1999;66:858-866.
49. Philipidis P, Mason JC, Evans BJ et al. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: anti-inflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res. 2004;94:119-126.
50. Kristiansen M Graversen JH, Jacobsen C et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409: 198-201.
51. Madsen M, Moller HJ, Nielsen MJ et al. Molecular characterization of the haptoglobin-hemoglobin receptor CD163. J Biol Chem. 2004;279:51561-51567.
52. Schaer CA, Schoedon G, Imhof A, Kurrer MD, Schaer DJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages. Circ Res. 2006;99:943-950.
53. Nielsen DP, Moller HJ, Moestrup SK. Hemoglobin and heme scavenger receptors. Antioxid Redox Signal. 2010;12:261-273.
54. Bover LC, Cardo-Vita M, Kuniyasu A et al. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol. 2007;178:8183-8194.
55. Moreno JA, Munoz-Garcia B, Martin-Ventura JL et al. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. Atherosclerosis. 2009;207:103-110.
56. Fabriek BO, van Bruggen R, Deng DM et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood. 2009;113:887-892.
57. Sanchez-Torrez C, Gomez-Puertas P, Gomez-del-Moral M et al. Expression of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection. Arch Virol. 2003;148:2307-2323.
58. van Gorp H, van Breedam W, Delputte PL, Nauwynck HJ. Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus. J Gen Virol. 2008;89:2943-2953.
59. Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine. 2007;40:1-16.
60. Maecker H, Vorlolomeev E, Kischkel F et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell. 2005;123:931-944.
61. Welch SKW, Calvert JG. A brief review of CD163 and its role in PPRSV infection. Virus Res. 2010; epub.
62. van Gorp H, van Breedam W, van Doorsselaere J, Delputte PL, Nauwynck HJ. Identification of the CD163 protein domains involved in infection of the porcine reproductive and respiratory syndrome virus. J Virol. 2010;84:3101-3105.
63. Hogger P, Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun. 2001;288:841-843.
64. Frings W, Dreier J, Sorg C. Only soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Letters. 2002;526:93-96.
65. Timmermann M, Buck F, Sorg C, Hogger P. Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type A. Immunol Cell Biol. 2004;82:479-487.
66. + T lymphocyte-rich microenvironments. Arthritis Rheum. 2002;46:1210-1216.
67. Kunz LIZ, Lapperre TS, Snoeck-Stroband JB et al. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir Res. 2011;12:34-42.
68. Higashi-Kuwata N, Jinnin M, Makino T et al. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther. 2010;12:R128.